| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.41 | 0.01 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |